Thrombotic Risk of Recombinant Factor Seven in Pediatric Cardiac Surgery: A Single Institution Experience
- 28 February 2010
- journal article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 89 (2), 570-576
- https://doi.org/10.1016/j.athoracsur.2009.11.023
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Transfusion-Related Acute Lung Injury: Current Concepts for the ClinicianAnesthesia & Analgesia, 2009
- Risks and Predictors of Blood Transfusion in Pediatric Patients Undergoing Open Heart OperationsThe Annals of Thoracic Surgery, 2009
- Evaluation of the Coagulation System in Children with Two-Ventricle Congenital Heart DiseaseThe Annals of Thoracic Surgery, 2007
- Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures — the importance of hemodynamics in the early postoperative period☆European Journal of Cardio-Thoracic Surgery, 2007
- Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice GuidelineThe Annals of Thoracic Surgery, 2007
- Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task ForceJournal of Thrombosis and Haemostasis, 2005
- Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis)The Journal of Thoracic and Cardiovascular Surgery, 2005
- Recombinant factor VIIa (NovoSeven®) as a hemostatic agent after surgery for congenital heart diseasePediatric Anesthesia, 2005
- Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the fontan procedureThe Annals of Thoracic Surgery, 2002
- Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operationCardiology in the Young, 1999